David Turner to Neoplasm Grading
This is a "connection" page, showing publications David Turner has written about Neoplasm Grading.
Connection Strength
0.252
-
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571.
Score: 0.155
-
ETS1 transcriptional activity is increased in advanced prostate cancer and promotes the castrate-resistant phenotype. Carcinogenesis. 2012 Mar; 33(3):572-80.
Score: 0.097